2010
DOI: 10.1016/j.biomaterials.2010.05.051
|View full text |Cite
|
Sign up to set email alerts
|

The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
42
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 45 publications
(52 citation statements)
references
References 42 publications
10
42
0
Order By: Relevance
“…As could be expected on the basis of previous studies with nonmodified (32,33) as well as RGD-modified Qdots (34), the major part of the injected dose (ID) was sequestered into the liver and spleen (Table S1). Highly interesting was the particle content in the eye.…”
Section: Resultssupporting
confidence: 73%
“…As could be expected on the basis of previous studies with nonmodified (32,33) as well as RGD-modified Qdots (34), the major part of the injected dose (ID) was sequestered into the liver and spleen (Table S1). Highly interesting was the particle content in the eye.…”
Section: Resultssupporting
confidence: 73%
“…The relatively low TOPO-PMAT QD uptake observed in the present study with the A549 and SVEC cell lines was not unexpected as these cells are not necessarily known to be particle scavengers. However, Praetner and colleagues (2010) have recently shown that QD nanoparticles can be taken up in vivo by capillary endothelial cells. Because these epithelial and endothelial type cells would potentially be exposed to QDs following intravenous administration for medical purposes, examination of the potential QD mediated toxicity in an additional battery of assays was warranted.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, anionic QDs have a relatively low residence time in the blood stream and preferably accumulate in organs. 505 On the other hand it was also shown that high doses of QDs could cause pulmonary vascular thrombosis by triggering the coagulation cascade via contact activation. 506 Understanding the interaction of QDs with blood cells would help to improve QD design for theranostic drug delivery purposes.…”
Section: In Vivo Investigationsmentioning
confidence: 99%